Diagnosis and Current Treatment Strategies for Adult and Juvenile Hereditary Hemochromatosis

References (34)

1. 1 Review on iron and its importance for human health.
2. 2 Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases [DOI]
3. 3 Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) [DOI]
4. 4 The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency [DOI]
5. 5 A Review on Iron Chelators in Treatment of Iron Overload Syndromes.
6. 6 How I treat hemochromatosis [DOI]
7. 7 Oral Iron Supplementation After Blood Donation [DOI]
8. 8 Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis [DOI]
9. 9 Molecular Diagnostic and Pathogenesis of Hereditary Hemochromatosis [DOI]
10. 10 Pathophysiological consequences and benefits of HFE mutations: 20 years of research [DOI]
11. 11 TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis [DOI]
12. 12 Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia [DOI]
13. 13 Non-HFE haemochromatosis [DOI]
14. 14 Ferroportin1 is required for normal iron cycling in zebrafish [DOI]
15. 15 Hereditary Hemochromatosis: Rapid Evidence Review.
16. 16 Diagnosis and Management of Hereditary Hemochromatosis [DOI]
17. 17 Molecular pathogenesis of iron overload [DOI]
18. 18 Chapter 6 Iron Homeostasis and Erythropoiesis [DOI]
19. 19 Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids [DOI]
20. 20 Control of Systemic Iron Homeostasis by the 3’ Iron‐Responsive Element of Divalent Metal Transporter 1 in Mice [DOI]
21. 21 Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report [DOI]
22. 22 Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies [DOI]
23. 23 Genetic Diagnosis in Hereditary Hemochromatosis: Discovering and Understanding the Biological Relevance of Variants [DOI]
24. 24 Bloodletting: Past and Present [DOI]
25. 25 A Late Presentation of a Fatal Disease: Juvenile Hemochromatosis [DOI]
26. 26 Hereditary hemochromatosis types 1, 2, and 3 [DOI]
27. 27 A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis [DOI]
28. 28 Molecular insights into mechanisms of iron transport [DOI]
29. 29 A History of Phlebotomy Therapy for Hemochromatosis [DOI]
30. 30 Juvenile Hemochromatosis [DOI]
31. 31 A brief history of hemochromatosis [DOI]
32. 32 Iron Chelation Therapy for Treatment of Cardiac Hemochromatosis [DOI]
33. 33 Hereditary Hemochromatosis [DOI]
34. 34 Hemochromatosis: discovery of the HFE gene.

Cited by 1